首页> 美国卫生研究院文献>Biomolecules Therapeutics >Marine-Derived Pharmaceuticals – Challenges and Opportunities
【2h】

Marine-Derived Pharmaceuticals – Challenges and Opportunities

机译:海洋衍生药物–挑战与机遇

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Marine biosphere is the largest one of the earth and harbors an enormous number of different organisms. Living conditions differ fundamentally from those in terrestrial environment. The production of specific secondary metabolites is an important adaption mechanism of marine organisms to survive in the sea. These metabolites possess biological activities which make them interesting as possible drugs for human. The review presents sources, chemistry, production and pharmacology of FDA approved marine derived pharmaceuticals arranged according to their therapeutic indication. Four of the presently seven approved drugs are used for the treatment of cancer. Each another one is applicated for treatment of viral diseases, chronic pain and to lower triglyceride level in blood. Some other products are of interest in diagnostic and as experimental tools. Besides, this article describes challenges in drug development from marine sources, especially the supply problem.
机译:海洋生物圈是地球上最大的生物圈,拥有大量不同的生物。生活条件与陆地环境根本不同。特定次级代谢产物的产生是海洋生物在海中生存的重要适应机制。这些代谢物具有生物活性,使其成为可能的人类药物。该综述介绍了根据治疗指征排列的FDA批准的海洋衍生药物的来源,化学,生产和药理学。目前已批准的七种药物中有四种用于治疗癌症。彼此适用于治疗病毒性疾病,慢性疼痛和降低血液中甘油三酸酯水平。其他一些产品在诊断和实验工具方面也很受关注。此外,本文介绍了海洋药物开发中的挑战,特别是供应问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号